UPDATE: Editas shares boosted as patent office rules in favor of Broad's CRISPR patents, but the fight will continue

The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard in a dispute over the patents around CRISPR gene editing technology.

Related Keywords

,Ineditas ,Crispr Cas9 ,Broad Institute Of Mit And Harvard ,Patent Challenge ,Gene Editing ,Rispr ,Cell Amp Gene Therapy ,Iotech Patent News ,University Of California ,Biotech ,Fierce Biotech Homepage ,